A blood pressure drug recall has been issued in the United States over possible metal contamination that could cause internal lacerations to soft tissue in the mouth, oesophagus, stomach or intestine.
Breckenridge Pharmaceutical is recalling one lot of 60mg propranolol hydrochloride extended-release capsules. The medicine was distributed to wholesalers and pharmacies nationwide between October 26 and November 4.
The affected capsules were supplied in bottles of 100 and carry lot number PK25110035, with an expiry date of May 2029. The company said it was not aware of any adverse events linked to the recalled product.
What to do with the recalled blood pressure medication
Patients who have the affected medicine should return any unused capsules to the pharmacy where they were bought, Breckenridge Pharmaceutical said.
Wholesalers, pharmacies and other retailers have been told to check their stock, quarantine any affected products and prevent them from being distributed.
Propranolol capsules are used to manage high blood pressure and may also be prescribed for conditions including chest pain, migraines and tremors.
Anyone who experiences a problem that may be connected to taking the capsules should contact a healthcare provider and report the incident through the US Food and Drug Administration’s MedWatch Adverse Event Reporting programme.
Questions about the recall can be directed to Breckenridge Pharmaceutical’s recall service provider, Qualanex, on 1-855-736-0807 from Monday to Friday between 9am and 5pm Eastern Time, or by email at recall@qualanex.com.
